Moods Disorders Completed Phase 1 / 2 Trials for Ketamine (DB01221)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00088699Rapid Antidepressant Effects of Ketamine in Major DepressionOther